Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 44 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Nivolumab adjuvant therapy for renal cell carcinoma	Nivolumab (Opdivo; BMS-936558; ONO-4538)	Renal cell carcinoma (RCC)	Renal Cancer	2023	View \| Download
Nivolumab and relatlimab for untreated advanced or metastatic melanoma – first line	Nivolumab (Opdivo; BMS-936558; ONO-4538) , Relatlimab (BMS-986016; Anti-LAG-3)	Melanoma	Skin Cancer	2019	View \| Download
Nivolumab for adjuvant and neoadjuvant treatment of localised renal cell carcinoma	Nivolumab (Opdivo; BMS-936558; ONO-4538)	Renal cell carcinoma (RCC)	Renal Cancer	2021	View \| Download
Nivolumab for adjuvant treatment of stage IB-IIIA non-small cell lung cancer	Nivolumab (Opdivo; BMS-936558; ONO-4538)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2021	View \| Download
Nivolumab for hepatocellular carcinoma - adjuvant	Nivolumab (Opdivo; BMS-936558; ONO-4538)	Hepatocellular carcinoma (HCC)	Gastrointestinal Cancer	2020	View \| Download
Nivolumab for high risk invasive urothelial carcinoma - adjuvant	Nivolumab (Opdivo; BMS-936558; ONO-4538)	Urothelial cancer	Urological Cancer	2019	View \| Download
Nivolumab for oesophageal or gastro-oesophageal junction cancer - adjuvant	Nivolumab (Opdivo; BMS-936558; ONO-4538)	Gastro-oesophageal junction cancer , Oesophageal cancer	Gastrointestinal Cancer , Head and Neck Cancer	2019	View \| Download
Nivolumab for platinum-resistant advanced or recurrent ovarian cancer	Nivolumab (Opdivo; BMS-936558; ONO-4538)	Epithelial ovarian cancer , Fallopian tube cancer , primary peritoneal cancer	Female Reproductive Cancer	2019	View \| Download
Nivolumab for treating advanced clear cell renal cell carcinoma after systemic treatment	Nivolumab (Opdivo; BMS-936558; ONO-4538)	Renal cell carcinoma (RCC)	Renal Cancer	2024	View \| Download
Nivolumab in addition to chemotherapy for advanced gastric cancer – first line	Chemotherapy , Nivolumab (Opdivo; BMS-936558; ONO-4538)	Gastric cancer	Gastrointestinal Cancer	2018	View \| Download